Would you like to speak to our regulatory affairs experts without having to worry about commitment, obligation or contracts?  The regulatory team at Kinesys Consulting will provide you with up to 30 minutes of complimentary consultation to help you decide

With the increasing acknowledgement of the need to develop an overarching scheme to enhance support for sponsors developing medicines, tackling unmet medical needs to ensure timely access to beneficial therapies, the EMA launched the PRIME scheme in March 2016. This

  Join top regulators, clinical, safety, and research professionals in health care and drug development. Discuss the biggest challenges, gain new, invaluable insights, and leave inspired to take action. The DIA EuroMeeting goal is to bring together key healthcare stakeholder

Kinesys Consulting last month secured another PIM designation, this time for a new oncology product, on behalf of a US partner. The product, successfully designated as a Promising Innovative Medicine (PIM) by the Medicines and Healthcare Products Regulatory Agency (MHRA), is being developed for the treatment of